InMode Breaks Above 200-Day Moving Average, Signaling Bullish Momentum
ByAinvest
Thursday, Oct 9, 2025 12:02 pm ET1min read
INMD--
For the full year 2025, InMode Ltd. expects revenue to be in the range of $365 million to $375 million, consistent with its prior guidance. This reaffirmation of earnings guidance indicates the company's confidence in its financial performance and market positioning.
InMode Ltd. is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. The company's products and solutions primarily address three energy-based treatment categories: face and body contouring, medical aesthetics, and women's health. Their proprietary technologies, such as Radio Frequency Assisted Lipolysis (RFAL) and Deep Subdermal Fractional RF, represent a paradigm shift in the minimally-invasive aesthetic solutions market [1].
The company's shares have been trending upwards, with a 52-week low of $13.14 and a high of $19.85, indicating a bullish trend for INMD. This upward movement could be attributed to the company's strong market position, innovative technology, and positive earnings guidance.
Investors and financial professionals should carefully review the associated descriptions and ratings provided by various financial platforms to gain a comprehensive understanding of InMode Ltd.'s performance and potential [1].
InMode Ltd's shares have broken above their 200-day moving average of $15.76, reaching a high of $16.74 per share, a 5.7% increase. The company's 52-week low is $13.14, with a high of $19.85. This indicates a bullish trend for INMD.
InMode Ltd. (INMD) has seen its shares break above the 200-day moving average, reaching a high of $16.74 per share, marking a 5.7% increase. This move comes as the company reaffirmed its earnings guidance for the third quarter and full year 2025. The company expects revenue for the third quarter of 2025 to be in the range of $92.5 million to $93.0 million [1].For the full year 2025, InMode Ltd. expects revenue to be in the range of $365 million to $375 million, consistent with its prior guidance. This reaffirmation of earnings guidance indicates the company's confidence in its financial performance and market positioning.
InMode Ltd. is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. The company's products and solutions primarily address three energy-based treatment categories: face and body contouring, medical aesthetics, and women's health. Their proprietary technologies, such as Radio Frequency Assisted Lipolysis (RFAL) and Deep Subdermal Fractional RF, represent a paradigm shift in the minimally-invasive aesthetic solutions market [1].
The company's shares have been trending upwards, with a 52-week low of $13.14 and a high of $19.85, indicating a bullish trend for INMD. This upward movement could be attributed to the company's strong market position, innovative technology, and positive earnings guidance.
Investors and financial professionals should carefully review the associated descriptions and ratings provided by various financial platforms to gain a comprehensive understanding of InMode Ltd.'s performance and potential [1].

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet